280 likes | 295 Views
This update provides information on the HIV and TB situation in the South-East Asia region, including prevalence, new infections, mortality, and progress towards the 90-90-90 targets. It also highlights key challenges and issues in tackling these diseases and outlines strategies for ending AIDS and controlling TB.
E N D
Update on HIV and TB situation in SEARDr Mukta SharmaRA HIV TB HEPWHO SEAROGlobal Fund , South-East Asia Constituency Meeting,23-24 April 2018, New Delhi
HIV/AIDScontinues to be a major public health problem • Overall adult prevalence in SEAR region is low (0.3%) • Approx. 10% of all PLHIV live in SEAR, an estimated 3.5 million, of these 39% are females • 99% of these 3.5 million are in five countries, India, Indonesia, Myanmar, Nepal and Thailand • Nearly 1.6 m are on ART • Nearly 150,000 new infections and 130,000 AIDS related deaths occurred in SEAR in 2016
HIV Prevalence in Key Populations Epidemic is concentrated among key populations in most countries in SEA
New HIV Infections 2014 – 2016 • SEAR New HIV Infections 2014 - 2016 • New HIV Infections 2016 per country (absolute, regional proportion and national rate per 1000 population) two thirds of the new infections are still occurring in key populations, PROGRESS REPORT ON THE PUBLIC HEALTH RESPONSE TO HIV IN THE WHO SOUTH-EAST ASIA REGION
HIV Mortality 2014 – 2016 Since the introduction of ART in the region in 2005, AIDS-related deaths have almost halved. However, annual progress has been slow, especially for the adult population • Estimated AIDS-related deaths in SEAR 2005, 2014 – 2016 • Estimated annual AIDS-related deaths 2016 (absolute, regional proportion and national rate per 1000 PLHIV)
Getting to 90-90-90Regional Cascade of testing and treatment 2016
SEAR Fast-Track Targets • reduce new HIV infections to below 50,000 in 2020 and below 20,000 in 2030; 150,000 as on December 2016 • reduce HIV-related deaths to below 45,000 in 2020 and below 18,000 in 2030; 130,000 as on December 2016 • Increase number of persons on treatment to 2.83 million in 2020 and 3.3 million by 2030; 1.4 million as on December 2016
Key issues/challenges • Two thirds of the new infections are still occurring in key populations, • Prevalence among PWID and MSM continue to be high in some countries • Newer forms of sex work, Migration & networks of MSM, TG, PWID are posing challenges and lack of access to real time data at local level for action is a barrier • Sustaining coverage & intensity in areas where declines have been achieved is critical to consolidate gains
Key issues/challenges • Though all countries have adopted TREAT ALL policy, reaching out to first 90 is challenging in most countries • ART coverage in region is 47% , varies widely between countries and is a slow as 20% in one country • Decline in new infections has slowed down post 2015 • Private sector involvement is not adequate enough, especially for elimination of MTCT in high burden countries • Preventing and tackling HIV drug resistance
Key issues/challenges • While most countries are providing free treatment services, declining donor funds have impacted prevention activities, IEC , community involvement etc. • Barriers on accessing services by KP need to be addressed • Six countries criminalize same-sex relations • Four impose criminal penalties for sex work • Four operate detention center for drug users • No statistics but members of key population report discrimination in healthcare settings • Ensuring social protection schemes for people infected and affected with HIV/AIDS • Ensuring a stigma free environment
It is possible to achieve Fast-track targets • Identify high risk communities, geographically and key populations • Design impact interventions, engaging communities to be part of the response • Front-load investment, especially on testing, diagnosis, and linkage to care • Create an enabling environment – Zero discrimination in laws, regulations, policies, and especially in the health sector • Strengthen information systems – progress needs to be monitored at local level
Status of tuberculosis and measures to control tuberculosis in South-East Asia Vineet Bhatia Technical Officer-TB/ WHO-SEARO
SEA Programme performance Closing gap between case notification and incidence, yet ~ 2 million missing Worrying decline in treatment success of DS-TB cases
SEA Region trends Source: Ending TB in the SEA Region: Strategic Plan 2016-20
Elements of Statement of Action 1 LEADimplementation of the national TB responses in countries by an empowered national initiative that reports to the highest levels of government in Member States 2 INCREASEbudgetary and human resource allocations by governments as well as by their global, domestic and other partners so as to ensure that national TB plans are fully funded 3 ENABLE the best possible care to each and every person, including migrants, the aged and other high-risk populations, living with any form of TB (through newer strategies) 4 SUPPLEMENTmedical care for TB with…social and financial protection in a holistic manner
Empowered National Initiative Patient Centred Approach Ensure Universal Access to high quality TB care • Increasing case finding, and case notifications and Improving treatment outcomes • Improving diagnosis and management of MDR-TB 11/11 11/11 11/11 Adopted the principles of a ”patient-centred approach High level Commitments to END TB High level national mechanism to direct implementation of NSP 10/11 5/11 4/11 Plans to engage civil society organizations Laid out plans to engage sectors outside the NTPs 3/11 2/11 2/11 Establishing Multi-sectoral collaboration Plans to address the development of new tools Countries may meet targets of ”zero catastrophic costs” by 2020
TB Funding 114% 525 million US$ 2017 245 million US$ 2016
Way forward – Member States • Establish multisectoral and empowered national initiatives in all Member States • Develop a national accountability framework • Estimate the financial resources needs for ending TB • Define a minimum standard package for universal access
Way forward – partners and WHO • Front load and scale up investments in high burden countries to cover current financing gaps • Establish financing channels for innovations • Define non-health elements of interventions and standardize unit costs • Innovation to Implementation (I2I) fund that would support innovation